{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-048251","form_type":"8-K","ticker":"MED","cik":"0000910329","company_name":"MEDIFAST INC","filed_at":"2025-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.569816+00:00","generated_at":"2026-05-17T01:02:12.601434+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"confidence":"high","headline":"Medifast Q3 revenue down 36% to $89.4M; net loss $2.3M; coaches drop 35%","bullets":["Revenue $89.4M vs $140.2M YoY; net loss $0.21 per diluted share vs $0.10 income.","Active earning OPTAVIA coaches fell to 19,500 from 30,000, due to GLP-1 competition.","Gross margin 69.5% vs 75.4% on fixed-cost de-leverage and $180 basis pts for product reformulation.","Q4 2025 guidance: revenue $65M–$80M; diluted loss per share $0.70–$1.25.","Cash & investments $173.5M; no debt."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-048251","json":"https://secwatch.observer/filing/0001628280-25-048251.json","markdown":"https://secwatch.observer/filing/0001628280-25-048251.md","text":"https://secwatch.observer/filing/0001628280-25-048251.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/910329/000162828025048251/0001628280-25-048251-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/910329/000162828025048251/med-20251103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:02:12.601434+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}